CRISPR Therapeutics Releases First Quarter 2026 Results Key Updates on Gene Editing Pipeline Senegals President Fires PM Dissolves Government Amid Deepening Debt Crisis Taiwan Arms Sales Emerge as Key Flashpoint in TrumpXi Talks Raising Stakes for Global Tech Supply Chains Oil Supply Near Critical Levels in Asia Europe Next Warns Carlyles Jeff Currie QXO Launches Hostile Takeover Bid for Beacon After Multiple Rejections Microns AI Memory Boom Signals Structural Shift Away from Cyclical Patterns WLDN Q1 2026 Earnings EPS Beat of 749 Surprise Drives Slight Stock Uptick GBLI Q1 2026 Earnings EPS Falls Short of Estimates as Underwriting Results Weigh TMO Q1 2026 Earnings EPS Surpasses Estimates by 284 Stock Edges Down THRY Q1 2026 Earnings Massive EPS Beat Lifts Shares as Expense Discipline Shines UAVS Q3 2023 Earnings EPS Beats Estimate Amid Revenue Absence Stock Surges 505 LKFN Q1 2026 Earnings Slight EPS Beat Amid Modest Stock Decline Atour Lifestyle Holdings ATAT Slips 545 Key Support Levels Come into Focus Intellia Therapeutics Slides Slightly Amid Cautious Trading in GeneEditing Sector INmune Bio Inc INMB Declines 2 as Stock Approaches Key Support Level Texas Community Bancshares Inc TCBS Slips 059 as Stock Tests Key Support Levels Axcelis Technologies ACLS Tests Support Levels After 15 Decline Goldman Sachs Russias Crude Exports Hold Steady Despite US Sanctions Oil Edges Lower Koppers Holdings Q1 2026 Earnings EPS Surges Past Estimates TAT Technologies TATT Edges Lower as Resistance Holds at 3892